Send this to a friend

Oxford Immunotec to receive $28M patent payout

U.K.-based Oxford Immunotec, with U.S. headquarters in Marlborough, has announced a $27.5 million settlement with a Germany-based company after a lengthy patent infringement suit.
Diagnostics firm Qiagen N.V., based in Hilden, Germany, will pay Oxford Immunotec the settlement for the right for a royalty-free, non-exclusive license to sell tuberculosis tests to current and future customers.
The settlement includes ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media